Inventor · disambiguated record
William C. Fanslow, Iii
Also filed as: FANSLOW III WILLIAM C · FANSLOW III WILLIAM CHRISTIAN · FANSLOW WILLIAM · FANSLOW WILLIAM C
61 granted patents·19 pending applications·2,179 citations·filing 1990–2022
99Inventor score
Files withIMMUNEX CORP54AMGEN INC15QILU PUGET SOUND BIOTHERAPEUTICS CORP4COSMAN DAVID J1DELANEY JOHN M1
Top patents by PatentIndex Score
80 records- 0197US5457035ACytokine which is a ligand for OX40IMMUNEX CORP·Filed 1993·Granted Oct 10, 1995·331 cites·8 claims
- 0296US9243058B2BCMA antigen binding proteinsAMGEN INC·Filed 2013·Granted Jan 26, 2016·83 cites·26 claims
- 0396US6087329ACD40 ligand polypeptideIMMUNEX CORP·Filed 1998·Granted Jul 11, 2000·122 cites·8 claims
- 0495US7807796B2ULBP antibodiesIMMUNEX CORP·Filed 2008·Granted Oct 5, 2010·19 cites·9 claims
- 0595US7741115B2Antibodies that bind LDCAMIMMUNEX CORP·Filed 2008·Granted Jun 22, 2010·22 cites·5 claims
- 0695US6680057B1Methods of treating autoimmune disease by administering interleukin-17 receptorIMMUNEX CORP·Filed 2000·Granted Jan 20, 2004·43 cites·22 claims
- 0794US10220090B2BCMA Antigen binding proteinsAMGEN INC·Filed 2015·Granted Mar 5, 2019·15 cites·17 claims
- 0894US7427669B2ULBP antibodiesIMMUNEX CORP·Filed 2006·Granted Sep 23, 2008·19 cites·18 claims
- 0994US5962406ARecombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the sameIMMUNEX CORP·Filed 1995·Granted Oct 5, 1999·96 cites·71 claims
- 1094US5869286AReceptor that binds IL-17IMMUNEX CORP·Filed 1996·Granted Feb 9, 1999·81 cites·12 claims
- 1193US7067475B2Tek antagonistsIMMUNEX CORP·Filed 2003·Granted Jun 27, 2006·33 cites·17 claims
- 1293US6653447B1ULBP DNA and polypeptidesIMMUNEX CORP·Filed 2000·Granted Nov 25, 2003·25 cites·32 claims
- 1393US6521424B2Recombinant expression of Tek antagonistsIMMUNEX CORP·Filed 2000·Granted Feb 18, 2003·37 cites·43 claims
- 1493US6264951B1Methods of inhibiting CD40L binding to CD40 with soluble monomeric CD40LIMMUNEX CORP·Filed 1996·Granted Jul 24, 2001·86 cites·2 claims
- 1593US5674492AMethod of preventing or treating disease characterized by neoplastic cells expressing CD40IMMUNEX CORP·Filed 1994·Granted Oct 7, 1997·126 cites·18 claims
- 1692US7405270B2CD40-Ligand lacking native-pattern glycosylationIMMUNEX CORP·Filed 2002·Granted Jul 29, 2008·32 cites·27 claims
- 1792US6072033AReceptor that binds IL-17IMMUNEX CORP·Filed 1998·Granted Jun 6, 2000·63 cites·8 claims
- 1891US10100121B2Anti-mesothelin binding proteinsAMGEN INC·Filed 2016·Granted Oct 16, 2018·5 cites·25 claims
- 1991US6410711B1DNA encoding CD40 ligand, a cytokine that binds CD40IMMUNEX CORP·Filed 1999·Granted Jun 25, 2002·64 cites·68 claims
- 2091US6072037AAntibodies to the IL-17 receptorIMMUNEX CORP·Filed 1998·Granted Jun 6, 2000·60 cites·6 claims
- 2191US5961974AMonoclonal antibodies to CD40 ligand, pharmaceutical composition comprising the same and hybridomas producing the sameIMMUNEX CORP·Filed 1994·Granted Oct 5, 1999·78 cites·8 claims
- 2290US10266604B2CD27L antigen binding proteinsAMGEN INC·Filed 2017·Granted Apr 23, 2019·8 cites·22 claims
- 2390US7074408B2Use of integrin antagonists to inhibit angiogenesisIMMUNEX CORP·Filed 2001·Granted Jul 11, 2006·49 cites·29 claims
- 2489US7193058B2ULBP antibodiesIMMUNEX CORP·Filed 2004·Granted Mar 20, 2007·21 cites·10 claims
- 2589US6458350B1ULBP DNA and polypeptidesIMMUNEX CORP·Filed 2000·Granted Oct 1, 2002·18 cites·12 claims
- 2689US6100235AMethods of treating immune and inflammatory response with IL-17 receptorsIMMUNEX CORP·Filed 1998·Granted Aug 8, 2000·48 cites·5 claims
- 2789US5565321ADetection of mutations in a CD40 ligand geneIMMUNEX CORP·Filed 1994·Granted Oct 15, 1996·56 cites·12 claims
- 2888US6197525B1Assay kits for detection and methods of inhibiting IL-17 bindingIMMUNEX CORP·Filed 1998·Granted Mar 6, 2001·46 cites·4 claims
- 2988US6096305AReceptor that binds IL-17IMMUNEX CORP·Filed 1998·Granted Aug 1, 2000·46 cites·10 claims
- 3088US5981724ADNA encoding CD40 ligand, a cytokine that binds CD40IMMUNEX CORP·Filed 1995·Granted Nov 9, 1999·65 cites·188 claims
- 3188US5801227AAntibodies to CD40Filed 1995·Granted Sep 1, 1998·99 cites·6 claims
- 3287US7829675B2TWEAK receptorIMMUNEX CORP·Filed 2009·Granted Nov 9, 2010·8 cites·8 claims
- 3387US7449555B2Antibodies of angiogenesis inhibiting domains CD148AMGEN INC·Filed 2005·Granted Nov 11, 2008·20 cites·19 claims
- 3487US6191104B1Methods of treating graft rejection with the IL-17 receptorIMMUNEX CORP·Filed 1998·Granted Feb 20, 2001·41 cites·3 claims
- 3585US7495086B2TWEAK receptorIMMUNEX CORP·Filed 2004·Granted Feb 24, 2009·17 cites·5 claims
- 3684US10465009B2BCMA antigen binding proteinsAMGEN INC·Filed 2013·Granted Nov 5, 2019·9 cites·23 claims
- 3784US8987422B2CD27L antigen binding proteinsDELANEY JOHN M·Filed 2012·Granted Mar 24, 2015·7 cites·29 claims
- 3883US9574008B2CD27L antigen binding proteinsAMGEN INC·Filed 2015·Granted Feb 21, 2017·4 cites·23 claims
- 3983US7659385B2Polynucleotides encoding molecules designated LDCAMIMMUNEX CORP·Filed 2008·Granted Feb 9, 2010·3 cites·14 claims
- 4083US7432237B2Methods of treating asthma by administering interleukin-17 receptorIMMUNEX CORP·Filed 2003·Granted Oct 7, 2008·9 cites·16 claims
- 4180US7402655B2Molecules designated LDCAMIMMUNEX CORP·Filed 2001·Granted Jul 22, 2008·8 cites·13 claims
- 4280US7273843B2Methods of treating allergy by administering interleukin-17 receptorIMMUNEX CORP·Filed 2003·Granted Sep 25, 2007·7 cites·18 claims
- 4380US7175849B2Nectin polypeptidesIMMUNEX CORP·Filed 2001·Granted Feb 13, 2007·18 cites·32 claims
- 4480US6290972B1Method of augmenting a vaccine response by administering CD40 ligandIMMUNEX CORP·Filed 1996·Granted Sep 18, 2001·26 cites·21 claims
- 4578US11124570B2Anti-PD1 and anti-CTLA4 antibodiesQILU PUGET SOUND BIOTHERAPEUTICS CORP·Filed 2017·Granted Sep 21, 2021·1 cites·12 claims
- 4677US5900238AVaccine delivery systemIMMUNEX CORP·Filed 1995·Granted May 4, 1999·56 cites·18 claims
- 4776US11427627B2Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profilesAMGEN INC·Filed 2014·Granted Aug 30, 2022·2 cites·18 claims
- 4873US6391637B1Use of CD40 ligand, a cytokine that binds CD40, to stimulate hybridoma cellsFiled 1996·Granted May 21, 2002·17 cites·35 claims
- 4971US11866508B2Anti-mesothelin binding proteinsAMGEN INC·Filed 2021·Granted Jan 9, 2024·0 cites·26 claims
- 5067US2005131648A1Screening assays for agonists or antagonists of CD40 signalingIMMUNEX CORP·Filed 2004·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →